glp 1 agonist vs sglt2 inhibitor GLP-1 receptor agonists and inhibitors: a couple at last? Kidney and Cardiovascular Effectiveness of
Description
We excluded patients who had any evidence of T2D
158,161,164,165 However, activating multiple receptors may lead to more complex side effects, and in some experiments, dual and triple agonists have indeed shown more severe side effects
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Based on this Unger argued that disruptions to the release of glucagon played an important role in the development of type 2 diabetes
